MedPath

Polak David

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs

Early Phase 1
Conditions
Peri-implant Mucositis
Interventions
Drug: Placebo Oral Tablet
Drug: Flurbiprofen
First Posted Date
2017-03-24
Last Posted Date
2017-03-31
Lead Sponsor
Polak David
Target Recruit Count
100
Registration Number
NCT03090009
Locations
🇮🇱

Hadassah Medical Organization, Jerusalem, Israel

Polymorphonuclear Cells' Sensitivity to Aggregatibacter Actinomycetemcomitans Bacteria in Patients With Aggressive Periodontitis

Not Applicable
Conditions
Periodontal Disease
Interventions
Other: blood extraction
First Posted Date
2013-12-12
Last Posted Date
2013-12-16
Lead Sponsor
Polak David
Target Recruit Count
75
Registration Number
NCT02010307
Locations
🇮🇱

Hadassah Medical Organization, Jerusalem, Israel, Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath